key: cord-0699663-86y1rhe8 authors: Maio, S. Di; Esposito, A.; Margonato, A.; Godino, C. title: Massive spontaneous subcutaneous emphysema and pneumomediastinum as rare complications of COVID-19 pneumonia. date: 2021-03-06 journal: J Cardiothorac Vasc Anesth DOI: 10.1053/j.jvca.2021.03.002 sha: 6a34646ab8793c966596f1e94c35caac95a3e66e doc_id: 699663 cord_uid: 86y1rhe8 nan We describe the case of a patient who developed spontaneous subcutaneous emphysema and pneumomediastinum after uncomplicated COVID-19 pneumonia. A 72-year old gentleman, with a previous history of glaucoma, Parkinson's disease in medical therapy, with recently diagnosed metastatic adenocarcinoma of the rectum treated with chemotherapy and no cardiopulmonary comorbidities, referred to the Emergency department (ED) complaining of dyspnea. On admission, he presented with fever (38.5°C), oxygen saturation of 90% breathing room air, and diffuse bilateral lung crackles. Nasopharyngeal swab resulted positive for SARS-CoV2. Chest X-Ray confirmed the diagnosis of interstitial pneumonia. He was efficaciously treated with intravenous dexamethasone, remdesivir, enoxaparin and low-flow oxygen; neither invasive nor positive pressure ventilation were necessary. He was discharged after 21 days in good general conditions, to follow home isolation according to the anti-COVID-19 regulations established by the Italian Ministry of Health, as his SARS-CoV-2 swab was still positive. However, the following day the patient started to present facial and neck swelling which increased significantly during the day and a typical dysphonia; he reported to have felt acute sharp pain to the neck three days before, immediately after exerting arm strain in an attempt to get out of the bed. This pain has been mistaken for "muscle tearing" pain. In retrospect, we can affirm it likely represented the moment of the pneumomediastinum occurrence, caused by muscular effort (like a strong Valsalva maneuver). As the swelling worsened, the patient was brought again to the ED. He did not complain of chest pain nor difficulty breathing and was afebrile, but characteristic clinical features of subcutaneous emphysema were evident at his face and neck. His vital signs showed blood pressure of 135/80 mmHg, heart rate of 80 bpm, oxygen saturation of 98%; physical examination revealed swelling and crackling-feel to the touch of his face and neck (Figure 1 It has been assessed that only about 1-2% of COVID-19 patients developed pneumothorax [1, 2] . While pneumothorax represents a well-known complication of COVID-19 patients necessitating invasive ventilation [3] , only a handful of cases of spontaneous pneumothorax and pneumomediastinum, have been described during coronavirus pandemic outbreak, as uncommon, life-threatening presentations of the disease [4] . Spontaneous subcutaneous emphysema represents an even rarer complication of COVID-19-related pneumonia, with only as few as about 20 cases described in literature so far, as resulted from a PubMed case reports analysis. Chest CT plays a 5 pivotal role in the diagnostic algorithm of these conditions, as it shows high sensitivity and a high negative predictive value [5] . Dyspnea and chest pain are the most frequent complaints at presentation. However, upon arrival to the ED, our patient was completely asymptomatic for shortness of breath and pain, as well as hemodynamically stable with a normal peripheral saturation, although he presented pneumothorax and a massive pneumomediastinum. Subcutaneous crackling was the only sign of disease which could be recognized. This subtle, deceptive clinical presentation could be explained by the fact that pneumomediastinum did not interfere remarkably with the patient's respiratory function and the patient was already on oxygen therapy because of his pneumonia. It is to note that the patient had Different mechanisms, such as anatomical abnormalities (i.e. emphysematous bullae), genetical predisposition (i.e. history of spontaneous pneumothorax), inflammatory-mediated lung stiffness (i.e. COVID-19-related pulmonary fibrosis), or intense physical stress (i.e. heavy coughing) may play a marginal role individually. However, if present together, they may significantly favor the occurrence of these serious complications. Clearly, more severe COVID-19 associated symptoms may be expression of a heavier inflammatory burden and could lead to greater respiratory effort and 6 more violent, persistent cough, which may all eventually promote alveolar cystic rupture [6] . Moreover, the marked disproportion in dimensions between the small pneumothorax and the massive pneumomediastinum, which was particularly evident in our patient (Fig. 2, Panels A and B ), may be explained by the pneumonia-related lung stiffness, that lead to greater air expansion in the more compliant mediastinum. Although a few cases of spontaneous pneumothorax and pneumomediastinum have been reported during the past months [7] [8] [9] [10] , the prognosis of these complications has not been established yet [11] . Conservative management is usually the treatment of choice. The patient must be cautioned against any form of coughing and straining, as they would increase intrathoracic pressure [12] . 100% oxygen therapy proved to be extremely efficacious in the disease management of our patient, with a rapid reabsorption of air trapping. When inhaling 100% oxygen, nitrogen is washed out of the blood, thus increasing the gradient for gas absorption and leading to a four-to six-fold increase in the rate of reduction of pneumothorax, subcutaneous and mediastinal emphysema [13] . Spontaneous subcutaneous emphysema and pneumomediastinum are rare, yet life-threatening complications of COVID-19 infection, which can occur days to weeks after the onset of pneumonia. Their occurrence may be promoted by more severe symptoms, which may lead to alveolar rupture by increasing intrathoracic pressure. While chest pain and dyspnea are the most common complaints, subtle symptoms should raise our attention as well, particularly in patients who have already recovered from COVID-19 pneumonia. Although the prognosis of these complications has not been established yet, treatment with 100% oxygen and best rest, in stable patients, appeared to represent an efficacious first-line approach to enhance air reabsorption. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Emergency tracheal intubation in 202 patients with COVID-19 in China: lessons learnt and international expert recommendations Case Report: Pneumothorax and Pneumomediastinum as Uncommon Complications of COVID-19 Pneumonia-Literature Review Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases COVID-19 with cystic features on computed tomography: A case report COVID-19 and Spontaneous Pneumomediastinum: A case series Case report: Spontaneous pneumothorax in resolved, uncomplicated COVID-19 Pneumonia -A literature review Spontaneous pneumomediastinum in a male adult with COVID-19 pneumonia Spontaneous pneumothorax and pneumomediastinum as a rare complication of COVID-19 pneumonia: Report of 6 cases Bilateral spontaneous pneumothorax in SARS-CoV-2 infection: a very rare, life-threatening complication A case of spontaneous cervical and mediastinal emphysema Noninvasive treatment of pneumothorax with oxygen inhalation